vialauditThe Roundup
GHRP-2·US LEGAL STATUS·LAST CHECKED 12 OCT 2026

Is GHRP-2 legal?

Not as a drug. GHRP-2 has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. It is approved in Japan (diagnostic), which has no effect in the US. Pharmacies cannot compound it.

RESEARCH-LABELLED SALE
Unapproved drug
PHARMACY COMPOUNDING
No
PRESCRIPTION
Not in US · approved in Japan (diagnostic)
WADA 2026
Prohibited (S2.2.4)

DESCRIBES THE LAW · NOT LEGAL ADVICE · NO DOSING INFORMATION

Federal, compounding and sport status

CHECKED 12 OCT 2026

Federal status

FDA approval
no approval · brand: GHRP Kaken 100 (Japan only)
DEA scheduling
not scheduled
503A compounding
FDA interim category: Category 3 (nominated without adequate support)
503A Bulks List: not on list
503A Category 3 (nominated without adequate support), which FDA's interim policy does not cover, so not eligible. In 503B Category 2 for injectable and nasal routes.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Unapproved drug; commercial sale for human use violates FDCA.
Personal possession: Not federally criminalized.

Sport-body status

WADA 2026
prohibited · class S2.2.4 · in and out of competition
Named under S2.2.4 as GHRP-2 (pralmorelin).
USADA
NCAA

State rules

NONE FOUND

We found no state statute, board rule or enforcement action that names GHRP-2. The federal position above applies in all 50 states and DC.

What changed at the last check

2 CHANGES
DateFieldWasNowWhy
12 Oct 2026WADA 2026prohibited (S2.2)prohibited (S2.2.4)Named under S2.2.4 as GHRP-2 (pralmorelin). source ↗
12 Oct 2026503A interim categoryremoved from Category 2 (Apr 2026)Category 3Corrected: GHRP-2 is in 503A Category 3 (nominated without adequate support); its Category 2 listing is for 503B only. source ↗

Questions

3 ANSWERS
Is GHRP-2 legal in the US?

Not as a drug. GHRP-2 has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. It is approved in Japan (diagnostic), which has no effect in the US. Pharmacies cannot compound it.

Can a pharmacy compound GHRP-2?

503A Category 3 (nominated without adequate support), which FDA's interim policy does not cover, so not eligible. In 503B Category 2 for injectable and nasal routes.

Is GHRP-2 banned in sport?

Yes. It is prohibited at all times under WADA 2026 class S2.2.4. Named under S2.2.4 as GHRP-2 (pralmorelin).

Sources

3 DOCUMENTS
  1. FDA approval record
  2. DEA controlled-substance schedules
  3. FDA 503A compounding position
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH